Vimeo
LinkedIn
Instagram
Share |

investment

April 19, 2022

Post COVID-19 pandemic, growth is now being crimped by global supply issues, fuelling higher inflation around the world—a trend that is not going to be as transitory as some people had initially hoped, says Titanbay's Hakki Mustafa.

April 19, 2022

In this week’s FB Roundup, Brewing heir Santo Domingo joins a Chelsea FC consortium; Twitter’s board of directors approves a ‘Poison pill’ strategy against Elon Musk’s takeover bid; and Sir Terence Conran’s former restaurant empire is up for auction.

Brewing heir Santo Domingo backs Chelsea FC takeover bid
Colombian-born billionaire brewing heir Alejandro Santo Domingo [picured left] has announced his backing for the bid to buy Chelsea Football Club.

Santo Domingo, who sits on the board of the world’s largest brewer ABInBev, has joined part of the investor group spearheaded by former Liverpool FC and British Airways chairman Sir Martin Broughton.

April 7, 2022

Events in Ukraine are to be seen, first, through the lens of humanity. Through the lens of finance, Russia’s invasion is having the same effect as Covid-19: it is accelerating trends which are already in place. And those trends are inflationary says Ruffer LLP chairman Jonathan Ruffer.

Events in Ukraine are to be seen, first, through the lens of humanity. Through the lens of finance, Russia’s invasion is having the same effect as Covid-19: it is accelerating trends which are already in place. And those trends are inflationary.

April 5, 2022

In this week’s FB Roundup, Elon Musk obtains a 9.2% stake in Twitter; Henry Sy’s family buy out Philippine Geothermal Production Co; and The Rockefeller Foundation makes a $105 million climate-friendly food pledge.

Elon Musk obtains 9.2% Twitter stake for $2.89 billion
Shares in social media titan Twitter have swollen by 25% after the world’s richest person Elon Musk [pictured left] bought a 9.2% stake for $2.89 billion.

The Tesla and SpaceX founder snapped up 73,486,938 Twitter shares in a move that has surprised many, particularly as Musk has been critical of the channel’s free-speech policies.

April 4, 2022

The Russia-Ukraine war adds to near-term growth risks for the global economy and will likely keep inflation elevated for longer. While uncertainty is high, equity markets are oversold and should recover if tensions ease in the coming months says Russell Investments’ global head of investment strategy Andrew Pease.

The Russia-Ukraine war adds to near-term growth risks for the global economy and will likely keep inflation elevated for longer. While uncertainty is high, equity markets are oversold and should recover if tensions ease in the coming months says Russell Investments’ global head of investment strategy Andrew Pease.


Key market themes

April 4, 2022

China’s bid for global power, climate change and the transition away from fossil fuels are three of the defining megatrends of our time. Collectively, they promise generational upheaval. But decades of peace and stability have left markets, politics, economies and societies complacent and vulnerable. It’s going to get bumpy says Ruffer LLP investment director Alexander Chartres.

China’s bid for global power, climate change and the transition away from fossil fuels are three of the defining megatrends of our time. Collectively, they promise generational upheaval. But decades of peace and stability have left markets, politics, economies and societies complacent and vulnerable. It’s going to get bumpy says Ruffer LLP investment director Alexander Chartres.

Note: This article was written in late 2021, before the Russian invasion of Ukraine.

March 31, 2022

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum, chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Using a new light-based non-surgical treatment, this cutting-edge treatment has already proved effective in clinical trials.

Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, Edinburgh Biosciences’ chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

March 24, 2022

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

March 21, 2022

Implementing a successful private markets program as part of a total portfolio is not without some implementation challenges, says Russell Investments’ alternative investments client portfolio manager Darren Spencer, and perhaps the most pressing issue investors face which needs to be solved for is managing the J-curve.

Click here >>
Close